FDA Drug Application (202189) for BUPROPION HYDROCHLORIDE by WOCKHARDT LTD

Back to FDA Applications sponsored by WOCKHARDT LTD

Application Number202189
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB3 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameBUPROPION HYDROCHLORIDE
Active IngredientBUPROPION HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BUPROPION HYDROCHLORIDE7


Back to FDA Applications sponsored by WOCKHARDT LTD